August 21, 2013

Bausch + Lomb and TheraPearl have teamed up to market the Bausch + Lomb TheraPearl Eye Mask, a new option for consumers suffering from a variety of common ailments, including the most common type of dry eye.

August 6, 2013

Valeant Pharmaceuticals announced it has completed its previously announced acquisition of Bausch + Lomb.

March 25, 2013

Bausch + Lomb announced that it has filed a registration statement with the U.S. Securities and Exchange Commission to take the company public.

February 26, 2013

Bausch + Lomb named Robert Bertolini as president and CFO effective immediately.

December 12, 2012

Bausch & Lomb is actively exploring a sale that could command upward of $10 billion, according to a report in The Wall Street Journal published Tuesday.

March 27, 2012

Bausch + Lomb will acquire eye drug maker Ista Pharmaceuticals for $9.10 per share in cash, or approximately $500 million.

March 18, 2011

Bausch + Lomb on Friday appointed a clinical professor of ophthalmology to serve as the company's first-ever chief medical officer.